Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-20-000016
Filing Date
2020-01-02
Accepted
2020-01-02 16:15:12
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 delmarph_fm4dec312019.html 4  
1 delmarph_fm4dec312019.xml 4 3449
  Complete submission text file 0000905718-20-000016.txt   4870
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4316 LOCARNO CRESCENT VANCOUVER A1 V6R 1G3
Business Address
Cranston Lynda Sarah (Reporting) CIK: 0001633660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 20501689